Furthermore, a variety of VEGF-blocking strategies have confirmed the critical role of VEGF in the permeability response of diabetic animal models [14], [15], [16], [17] and have shown a reduction in vascular permeability in patients with diabetic macular edema [18], [19], [20], [21]. This evidence concerns the gene VEGFA and diabetic macular edema.